Background and Purpose-Limited data exist on the comparative recovery patterns and outcomes of patients with ischemic stroke and intracerebral hemorrhage in China. Methods-Data on baseline characteristics and outcomes of 6354 patients at 3 and 12 months poststroke are from
L ike in many nations across the world, stroke is 1 of the leading causes of mortality and morbidity in China. 1 However, as China reaps the benefits of recent rapid economic development and resultant increases in life expectancy, 2 it is also confronted with the challenges of an escalating burden of chronic diseases in its massive population of 1.3 billion residents. 3 An assessment of clinical prognosis is useful for prioritizing (and rationalizing) healthcare resources, particularly for costly diseases such as stroke. However, although there have been many studies of the predictors of mortality and functional outcome for stroke using a plethora of outcome measures, including research in Asia 4 -6 and in China, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] these are often limited by sample size, geographic location, and stroke type. The aims of our study were therefore to compare recovery patterns and determine factors associated with a poor outcome for the major stroke types of ischemic stroke (IS) and intracerebral hemorrhage (ICH) in a broad range of hospitalized patients in China.
Methods

Study Design
ChinaQUEST (QUality Evaluation of Stroke Care and Treatment) was a multicenter, prospective, hospital (nϭ62) registry study in 37 cities in China, as described elsewhere. 18 In brief, consecutive patients (aged Ն15 years) admitted to a hospital with a recent acute stroke due to IS or ICH were included during a 5-month period in 2006. Patients underwent 4 assessments at baseline (done as soon as possible after notification), time of discharge, and approximately 3 and 12 months poststroke. Baseline information on demographics and medical history was obtained predominantly by face-to-face interviews and medical records, whereas those pertaining to functional outcome as measured by modified Rankin Scale (mRS) 19 at 3 and 12 months were obtained mainly by telephone interview (Ͼ80%). Information on the likely cause and location of those patients who died during follow-up was obtained as soon as possible after notification. Death was ascertained by family (64.7%), a health professional (18.4%), records (eg, medical, police [11.8%] ), death certificate (3.5%), or another source (1.5%). Written informed consent was obtained from all patients or an appropriate family member (in situations in which the patient was disabled) to participate. The study was approved by the ethics committees of Peking University First Hospital (Beijing), Ruijin Hospital (Shanghai), Prince of Wales Hospital (Hong Kong), and The University of Sydney. Good Clinical Practice guidelines in accordance with the Declaration of Helsinki were used and the privacy of patients was strictly protected.
Explanatory and Outcome Variables
Baseline characteristics considered included sociodemographic variables (age, sex, marital status, living alone, low level of education [primary education only or illiterate], active employment [part-time or full-time], annual household income), medical history, and clinical features. Medical history investigated included: hypertension, diabetes, hyperlipidemia, atrial fibrillation, prior stroke, prior coronary artery disease (includes any history of heart attack/myocardial infarction, angina, or coronary heart disease) either self-reported or diagnosed in-hospital poststroke (patients whose total cholesterol level was Ն5.20 mmol/L 20 in-hospital were also classified as hyperlipidemic); prior dependency, current cigarette smoking, regular alcohol consumption within the 3 months before stroke onset, and being overweight (body mass index Ն24 kg/m 2 ). 20 Clinical features considered included time of presentation to the hospital, severe admission (Glasgow Coma Scale [GCS]) score (defined as 3 to 8 of a maximum of 15), and total anterior cerebral syndrome (TACS) subtype of stroke as per the Oxfordshire Community Stroke Project classification. The influence of management strategies on 12-month outcomes was also examined. For ICH, the effects of intravenous steroids, neuroprotectants (including edaravone, ganglioside GM1, cattle encephalon glycoside and ignotine, cinepazide, citicoline), hemodiluting agents (such as mannitol), and traditional Chinese medicine (alternative/herbal medicine) use in-hospital, and antihypertensive use during the months poststroke were assessed; whereas for IS, the effect of intravenous thrombolysis in-hospital and antiplatelet and lipid-lowering therapy poststroke were additionally investigated. Outcome as measured by the mRS was assessed in 2 ways: dichotomized into good (survival or nondependency [mRS score of 0 to 2]) and poor (death or dependency [mRS score of 3 to 5]) and as a graduated score. The mRS is scored 0 to 5 with: 0, no symptoms; 1, no significant disability; 2, slight disability; 3, moderate disability; 4, moderately severe disability; and 5, severe disability. 21 
Statistical Analysis
Logistic regression was used to determine factors associated with poor outcome at 3 and 12 months poststroke. Univariate analyses were followed by multivariate analyses adjusting for age (as a continuous variable), sex, and initially significant factors in which checks were also made for plausible interactions between main effects. The effect of medical management on the combined outcome variable death/dependency as well as on death per se and dependency per se at 12 months poststroke was also assessed using this approach. Separate modeling using logistic generalized estimating equations was performed to examine recovery patterns between IS and ICH with a different quadratic trend to actual time of assessment (weeks since onset) included a priori as a covariate and good outcome as a model outcome. A different intercept and linear slope but a common quadratic term was fitted to the IS and ICH data. Inclusion of the quadratic term was supported by quasilikelihood under the independence model criterion scores. An exchangeable correlation structure was used to account for any within-patient correlation. Wald tests were performed to assess the statistical significance of differences. Data are presented with ORs and 95% CIs. Statistical significance was considered at PϽ0.05. Time course of recovery curves was constructed using the predicted values and 95% CI from the final generalized estimating equations model. All analyses were conducted using STATA 10.1 (StataCorp LP, College Station, Texas). 
Results
In total, 13 038 patients were screened for eligibility. Of these, 30.9% were ineligible, 16.1% refused to participate, 1.5% died rapidly before enrolment, and the remainder 1.5% were not included for other reasons. This resulted in 6508 enrolled patients, of whom 154 were further excluded due to uncertainty of diagnosis and missing data, bringing the total study population to 6354 cases. Table 1 shows the baseline characteristics of the study population by stroke type. Compared with patients with IS, nearly twice as many patients with ICH patients to the hospital within 6 hours of onset and Ͼ4 times as many had a severe GCS score on admission. Tables 2 and 3 present univariate and multivariate associations of baseline characteristics with a poor outcome at 12 months poststroke, respectively. No significant interaction effects were detected in the multivariate analyses. Associations between baseline characteristics and a poor outcome did not differ greatly between 3 and 12 months (data not shown) with the exception of multivariate analyses for the earlier time point, in which for IS, females (ORϭ1.22, Pϭ0.02) and low-educated patients (ORϭ1.25, Pϭ0.005) additionally had a higher risk of death or dependency, but subjects with hyperlipidemia did not (ORϭ0.91, Pϭ0.20); and for ICH, hypertension (ORϭ1.51, Pϭ0.02) and prior stroke (ORϭ1.37, Pϭ0.04) were additionally associated with a poor outcome, whereas atrial fibrillation was omitted from the multivariate model because it did not reach significance in the univariate analyses.
With regard to management, multivariate analyses showed that in-hospital use of intravenous steroids was associated with a poor outcome for both stroke types, whereas there was no relation of intravenous neuroprotectants and outcome ( Table 3 ). Intravenous traditional Chinese medicine and hemodiluting agent use were associated with a poor outcome for IS, but antiplatelet and lipid lowering therapy post-IS significantly reduced this risk. In addition, although antihypertensive use poststroke halved the risk of poor outcome for ICH, there was only weak evidence for benefit in IS. Figure 1 shows the distribution of death and mRS scores for patients with IS and ICH in-hospital and at follow-up with a higher case-fatality in patients with ICH evident at all time points. By 12 months, 415 and 369 patients with ICH were dead and dependent, respectively; whereas 491 and 942 patients with IS were dead and dependent, respectively. In †Model run on Nϭ4645 for death/dependency, on Nϭ4782 for death, and on Nϭ4154 for dependency. ‡Model run on Nϭ4582 for death/dependency, on Nϭ4718 for death, and on Nϭ4104 for dependency, omitting missing values of GCS; models were adjusted for age, sex, and baseline variables shown to be significantly associated (PϽ0.05) with outcome in univariate analyses.
§No. of patients on therapy based on outcome status: Nϭ784/740 (yes/no) for death/dependency, Nϭ415/1157 (yes/no) for death, and Nϭ369/740 (yes/no) for dependency.
Model run on Nϭ1524 for death/dependency, on Nϭ1572 for death, and on Nϭ1109 for dependency. ¶Model run on Nϭ1509 for death/dependency, on Nϭ1556 for death, and on Nϭ1096 for dependency, omitting missing values of GCS; models were adjusted for age, sex, and baseline variables shown to be significantly associated (PϽ0.05) with outcome in univariate analyses.
logistic generalized estimating equations modeling, the incorporation of a quadratic time term resulted in a better model (lower quasilikelihood under the independence model criterion value). The Wald tests comparing the time course of recovery (slopes or overall) of the 2 stroke types ( Figure 2 ) were significant (PϽ0.001), thereby providing strong evidence that pattern of recovery after stroke was significantly different between patients with IS and those with ICH. The ORs for a good outcome at 3 and 12 months poststroke for patients with IS compared with patients with ICH were 2.62 (95% CI 2.36 to 2.91) and 1.98 (95% CI 1.76 to 2.24), respectively.
Discussion
This study presents an overview of the outcome and recovery patterns in hospitalized patients after acute stroke in China. Trajectories of recovery were significantly different by stroke type with patients with ICH improving faster initially than patients with IS, a finding consistent with existing literature. [22] [23] [24] [25] Conversely, prognostic factors were comparable between the 2 stroke types heavily driven by age, prior dependency, and initial severity. In addition, multivariate associations between baseline characteristics and poor outcome at 3 months were almost analogous to those at 12 months. A possible explanation for this similarity is that the great majority (95%) of patients achieve most neurological recovery within 11 weeks after stroke onset 26 ; thus, a model of outcomes at the 2 time points would be almost identical.
In terms of individual factors, age, prior stroke, prior dependency, diabetes, atrial fibrillation, severe admission GCS score, and TACS were all found to be correlated with poor outcome at 12 months for IS, consistent with other studies in China, Asia, and Europe 6,13,16,27-29 Our results also indicate that females were disadvantaged at 3 months poststroke but by 12 months poststroke, their risk of poor outcome was essentially identical to that of males. This initial increase in risk for females is also analogous to recent reports from a large hospital-based registry in Korea and has been attributed to baseline demographic differences between males and females. 30 Remarkably, hypertension was not significantly associated with poor outcome at either time point. Although similar results have been found in China, 31 a systematic review showed that high systolic and diastolic blood pressure was associated with death/dependency in patients with IS. 32 However, it is important to note that the reported U-shaped relationship between outcome after IS and blood pressure such that the worst outcomes occur at the lowest and highest blood pressures 33 is complicated by reverse causality in which patients with the most severe strokes have the lowest blood pressures. In addition, we also found that hyperlipid- emia offered better prognosis at 12 months but exerted no effect on 3-month outcome. Although comparable with results from the Chinese Chengdu Stroke Registry, 11 the result is contrary to expectations and may reflect improved quality of care for those who already have high cardiovascular risk and/or for the wealthy who can afford expensive blood tests necessary to diagnose hyperlipidemia. Indeed, when comparing patients with IS with and without reported hyperlipidemia, those with hyperlipidemia were significantly wealthier, better educated, and had significantly more cardiovascular comorbidities.
Interestingly, early time to hospital presentation was found to pose a negative influence on both 3-and 12-month outcomes in patients with IS. Our finding contrasts with a recent study of Japanese patients 34 and when an early presentation would allow an opportunity for initiation of thrombolysis. It is likely, however, that this association is partially confounded by patients with severe stroke being more likely to present earlier than those with mild stroke. Indeed, in our study, 60% of those with severe IS (GCS 3 to 8) presented within 6 hours of onset, whereas only 28% of those with mild IS (GCS Ͼ8) presented early. Moreover, the assessment of thrombolysis as a significant prognostic indicator is complicated by its use in only a small number of subjects. Although antihypertensive use in the postacute setting was only marginally protective against poor outcome, we recognize that this may have been due to limitations of the composite end point used in the primary analysis. Indeed, when death alone was examined, antihypertensive use was highly protective, whereas when dependency alone was assessed, there was a trend toward a detrimental effect, although this maybe confounded by increased antihypertensive therapy use in those with high cardiovascular risk.
For patients with ICH, age, prior dependency, severe GCS score on admission, and TACS all increased the risk of poor outcome at 3 and 12 months. Although there are few comparable studies in patients with ICH, initial stroke severity as measured by the National Institutes of Health Stroke Scale was predictive of a poor outcome in studies in Hong Kong 8 and with age and prior stroke in Japan. 4 Surprisingly, an early time to hospital presentation was also associated with a poor outcome, but this finding corresponds with results reported by Naganuma et al and has been attributed to greater hematoma growth in the early hours of ICH. 34 In contrast to IS, low education was found to be consistently associated with increased risk of poor outcome at both 3 and 12 months post-ICH. One possible explanation is that ICH is a more severe condition than IS and that access and engagement in rehabilitation may be more relevant to optimal recovery. Hypertension at baseline was correlated with poor outcome at 3 months post-ICH, but this effect did not extend to 12-month outcomes, a result that corresponds with data observed in other studies in the region. 31, 35 Nevertheless, antihypertensive use during the 3 months post-ICH provided significant protection against poor outcome at 12 months.
Our study does have limitations that deserve comment. First, we were unable to assess important physiological and clinical characteristics such as lesion location and size, known to be important predictors of outcome. 4, 5, 36 Nonetheless, to some extent these features are captured within the TACS classification. Second, the study only included patients presenting to participating hospitals who consented to the study. The requirement of informed consent may have precluded those who died rapidly on admission and those with minor strokes who did not wish to participate. However, given the extensive geographic coverage of the study and the large number of patients enrolled in the study, we believe the results are still valuable in providing an overview of the characteristics associated with poor outcome among hospitalized patients with stroke. Third, outcome on follow-up was assessed predominantly by telephone, which may question the validity of these scores, and death was predominantly ascertained by family. Nevertheless, assessment of the mRS by telephone has been reported to achieve good agreement with face-toface assessment in patients with stroke. 37 In addition, the consistency of our results with similar studies in China, Asia, and beyond provides further reassurance of the validity of our data.
In summary, although ICH and IS have different recovery trajectories in China, they share similar prognostic factors. These findings may assist clinicians in the management of their patients and for resource allocation in low-income settings.
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